Profound Medical (PROF) Liabilities and Shareholders Equity (2018 - 2026)

Profound Medical has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $73.5 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 20.69% year-over-year to $73.5 million; the trailing twelve-month figure through Mar 2026 stood at $242.9 million (up 9.08% YoY), and the FY2025 full-year result was $77.5 million, up 10.31% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $73.5 million, down from $77.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $77.5 million in Q4 2025, with the low at $61242.0 in Q1 2023.
• Average Liabilities and Shareholders Equity over 5 years is $51.5 million, with a median of $56.8 million recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity plunged 31.77% in 2023 and surged 93040.33% in 2024.
• Tracing PROF's Liabilities and Shareholders Equity over 5 years: stood at $64.4 million in 2022, then sank by 31.77% to $44.0 million in 2023, then surged by 59.78% to $70.2 million in 2024, then grew by 10.31% to $77.5 million in 2025, then retreated by 5.19% to $73.5 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $73.5 million (Q1 2026), $77.5 million (Q4 2025), and $42.3 million (Q3 2025), per Business Quant data.

Peer Comparison